Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belumosudil for IF/TA in Kidney Transplant
NCT06751602Phase 2Enrolling by invitation
- Sponsor
- Houston Methodist Research Institute
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belumosudil in kidney transplant rejection, Renal Tubular Atrophy, sponsored by Houston Methodist Research Institute. Started Sep 2025; status: enrolling by invitation.
02
Drugs
belumosudil
03
Conditions
kidney transplant rejectionRenal Tubular Atrophy
Beyond the preview
Go deeper on NCT06751602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06751602.